PSYBIO THERAP. (SUB.VT.)

PSYBIO THERAP. (SUB.VT.)

Share · CA6936971044 · A2QQYS (XTSX)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PSYBIO THERAP. (SUB.VT.)
No Price
28.04.2026 20:00
Current Prices from PSYBIO THERAP. (SUB.VT.)
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
PSYBF
USD
28.04.2026 20:00
0,00001 USD
0,00 USD
Company Profile for PSYBIO THERAP. (SUB.VT.) Share
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.

Company Data

Name PSYBIO THERAP. (SUB.VT.)
Company PsyBio Therapeutics Corp.
Website https://www.psybiolife.com
Primary Exchange XTSX TSX-V
WKN A2QQYS
ISIN CA6936971044
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Evan Mike Levine
Country United States of America
Currency EUR
Employees 0,0 T
Address 4400 West Sample Road, 33073 Coconut Creek
IPO Date 2021-02-25

Ticker Symbols

Name Symbol
Over The Counter PSYBF
TSX-V PSYB.V
More Shares
Investors who hold PSYBIO THERAP. (SUB.VT.) also have the following shares in their portfolio:
CHEVRON USA 20/23
CHEVRON USA 20/23 Bond
DZ BANK IS.A3013
DZ BANK IS.A3013 Bond